EXHIBIT 32.2

              SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the quarterly report (the "Report") of China
Biopharmaceuticals Holdings, Inc. (the "Company") on Form 10-QSB for the quarter
ended September 30, 2007 as filed with the Securities and Exchange Commission on
the date hereof, I, HUANG Chentai, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Date:  November 19, 2007                  By: /s/ HUANG Chentai
                                           -------------------------------------
                                           HUANG Chentai
                                           Chief Financial Officer